The Harvard Drug Group LLC recalls Memantine Hydrochloride Extended-Release
- Recalling company
- The Harvard Drug Group LLC
- Product
- Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
- Reason
- Failed Dissolution Specifications
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Mar 24, 2026
- Reported
- Apr 22, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- N/A
- Lot / codes
- Lot # N02425, Exp Date: 05/31/2027.
- Company location
- Dublin, OH
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0485-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0485-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.